- NWL.AX
- CYL.AX
- 4DX.AX
Inflation in the US recently hit 3.7%, helped by a sharp move in energy costs. This has reminded investors how quickly conditions can change and how powerful earnings growth can be when inflation bites into savings. Australian high growth potential stocks screened for both profit expansion and financial resilience offer one way to stay on the front foot. This article highlights three standouts from that group.
The three stocks highlighted here offer a compelling starting point if you want exposure to healthy high growth potential businesses that still keep an eye on balance sheet strength. However, if you want the standouts, these 34 best high growth potential stocks are the most outstanding.
4DMedical develops non invasive lung imaging software and scanners that quantify how air moves through the lungs. This is a direct fit with the Healthy high growth potential theme, as its XV LVAS and CT:VQ tools support both clinical care and drug development workflows.
The business currently reports about A$7 million in revenue from medical technology research and development of lung function analysis, with a market value of roughly A$2.46b.
4DMedical matters here because its respiratory imaging platform is built around a clear medical need. The screener theme focuses on companies where earnings are expected to ramp from that sort of focused product engine while the balance sheet remains in acceptable shape.
“Partnership with Philips promised a $10Million USD minimum order commitment contract over the next 2 years starting December 2025 (over 2026 and 2027). Philips has added 4DMedicals CT:VQ technology as an official product on their catalog in North America.”
What happens if a single assumption in that growth path shifts, for better or worse, will likely matter a lot for future earnings traction.
That sensitivity to even one input is exactly what makes the full narrative for 4DMedical so useful for seeing where 4DMedical’s story could accelerate or stall next.
Catalyst Metals is a Perth based gold producer and explorer focused on the Plutonic Gold Belt, where mine development and resource work align closely with the Healthy high growth potential theme. The group generated about A$629 million from Western Australia operations and has a market value near A$1.46b.
Catalyst Metals reports A$631.94 million in sales and A$171.12 million in net income, all tied to Australian operations, with the Plutonic projects central to expectations for earnings over the next three years. Investor attention now hinges on what happens if a single development milestone shifts.
